Skip to main content
SpringerLink
Log in

Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

In severely obese patients with type 2 diabetes (T2DM), the metabolic benefits after biliopancreatic diversion (BPD) are due to mechanisms independent of weight loss. Therefore, the anti-diabetic effect of BPD in overweight or mildly obese T2DM patients was investigated.

Methods

Ninety T2DM patients with BMI 25–35 underwent BPD and were evaluated 1 and 5 years after the operation (follow-up rate 100 and 83%, respectively).

Results

T2DM control (Hb1Ac < 7%) and remission (Hb1Ac < 6 without antidiabetics) was observed in 86.6 and 65% of cases at 1 year and 64.0% and 26.5% at 5 years, respectively. The long-term T2DM remission was predicted by baseline BMI value. Both before BPD and throughout the follow-up period, HOMA values were similar in the metabolically successful and unsuccessful subjects, while C-peptide normalized for FBG value as a marker of beta cell mass and insulin secretion increased progressively only in the former from 1.06 ± 0.64 to 1.44 ± 1.08 mcg/l ml/dl−1 * 100 (p < 0.002).

Conclusions

In T2DM patients with BMI of 25–35, a positive metabolic outcome is less frequent than in their counterparts with morbid obesity. In T2DM overweight patients, in spite of a short-term normalization of FBG and HbA1c levels and a well-sustained increase of insulin sensitivity, a long-term T2DM relapse occurs in the majority of the cases. While the surgically obtained decrease in insulin resistance leads to T2DM control in half of the patients, the increase in insulin secretion is mandatory for T2DM stable remission.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005;28:2406–11.

    Article  PubMed  Google Scholar 

  2. Jacobsen SH, Olesen SC, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22:1084–96.

    Article  CAS  PubMed  Google Scholar 

  3. Holst JJ. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. Curr Opin Pharmacol. 2013;13:983–8.

    Article  CAS  PubMed  Google Scholar 

  4. Mingrone G, Nolfe G, Gissey GC, et al. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion. Diabetologia. 2009;52:873–81.

    Article  CAS  PubMed  Google Scholar 

  5. Astiarraga B, Gastaldelli A, Muscelli E, et al. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. J Clin Endocrinol Metab. 2013;98:2765–73.

    Article  CAS  PubMed  Google Scholar 

  6. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55:2025–31.

    Article  CAS  PubMed  Google Scholar 

  7. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.

    Article  CAS  PubMed  Google Scholar 

  8. Falkén Y, Hellström PM, Holst JJ, et al. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab. 2011;96:2227–35.

    Article  CAS  PubMed  Google Scholar 

  9. Hinlst JJ. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. Curr Opin Pharmacol. 2013;13:983–8.

    Article  CAS  Google Scholar 

  10. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, et al. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes. 2003;52:1098–103.

    Article  CAS  PubMed  Google Scholar 

  11. Briatore L, Salani B, Andraghetti G, et al. Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity. Obesity (Silver Spring). 2010;18:932–6.

    Article  CAS  Google Scholar 

  12. Briatore L, Salani B, Andraghetti G, et al. Restoration of acute insulin response n T2DM subjects 1 month after biliopancreatic diversion. Obesity (Silver Spring). 2008;16:77–81.

    Article  Google Scholar 

  13. Scopinaro N, Camerini G, Papadia F, et al. Long term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non–morbidly obese patients undergoing biliopancreatic diversion. Surg Obes Relat Dis. 2016;12:345–9.

    Article  PubMed  Google Scholar 

  14. Scopinaro N, Adami GF, Papadia FS, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m2) and simple overweight (BMI 25-30 kg/m2): a prospective controlled study. Obes Surg. 2011;21:880–8.

    Article  PubMed  Google Scholar 

  15. Scopinaro N, Adami GF, Papadia FS, et al. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg. 2011;253:699–703.

    Article  PubMed  Google Scholar 

  16. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.

    Article  CAS  PubMed  Google Scholar 

  17. Meier JJ, Menge BA, Breuer TG, et al. Functional assessment of pancreatic beta-cell area in humans. Diabetes. 2009;58:1595–603.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE investigators. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376:641–51.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Panunzi S, Carlsson L, De Gaetano A, et al. Determinants of diabetes remission and glycemic control after bariatric surgery. Diabetes Care. 2016;39:166–74.

    Article  CAS  PubMed  Google Scholar 

  21. Camerini GB, Papadia FS, Carlini F, et al. The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes. Surg Obes Relat Dis. 2016;12:345–9.

    Article  PubMed  Google Scholar 

  22. Scopinaro N, Adami GF, Bruzzi P, et al. Prediction of diabetes remission at long term following biliopabcreatic diversion. Obes Surg. 2017;27:1705–8.

    Article  PubMed  Google Scholar 

  23. Müller-Stich BP, Senft JD, Warschkow R, et al. Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg. 2015;261:421–9.

    Article  PubMed  Google Scholar 

  24. Horwitz D, Saunders JK, Ude-Welcome A, et al. Three-year follow-up comparing metabolic surgery versus medical weight management in patients with type 2 diabetes and BMI 30–35.

  25. Cummings DE, Cohen RV. Bariatric/metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg/m2. Diabetes Care. 2016;39:924–33.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Di J, Zhang H, Yu H, et al. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m(2). Surg Obes Relat Dis. 2016;12:1357–63.

    Article  PubMed  Google Scholar 

  27. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–256.e5.

    Article  PubMed  Google Scholar 

  28. Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297–304.

    Article  CAS  PubMed  Google Scholar 

  29. Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE Investigators. .Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370:2002–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Faradji RN, Monroy K, Messinger S, et al. Simple measures to monitor beta-cell mass and assess islet graft dysfunction. Am J Transplant. 2007;7:303–8.

    Article  CAS  PubMed  Google Scholar 

  31. Ritzel RA, Butler AE, Rizza RA, et al. Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care. 2006;29:717–8.

    Article  PubMed  Google Scholar 

  32. Saisho Y, Butler AE, Manesso E, et al. β-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 2013;36:111–7.

    Article  PubMed  Google Scholar 

  33. Halban PA, Polonsky KS, Bowden DW, et al. β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. Diabetes Care. 2014;37:1751–8.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Janikiewicz J, Hanzelka K, Kozinski K, et al. Islet β-cell failure in type 2 diabetes—within the network of toxic lipids. Biochem Biophys Res Commun. 2015;8(460):491–6.

    Article  CAS  Google Scholar 

  35. Weir GC, Bonner-Weir S. Islet β cell mass in diabetes and how it relates to function, birth, and death. Ann N Y Acad Sci. 2013;1281:92–105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Paniagua JA. Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome. World J Diabetes. 2016;7:483–514.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371:2237–8.

    Article  CAS  PubMed  Google Scholar 

  38. Matveyenko AV, Butler PC. Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab. 2008;10(Suppl 4):23–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Porte Jr D, Kahn SE. Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes. 2001;50(Suppl 1):S160–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Genova, 8, Viale Benedetto XV, 16132, Genoa, Italy

    Gian Franco Adami & Renzo Cordera

  2. Department of Internal Medicine and Surgery, University of Genova, Genoa, Italy

    Giovanni Camerini, Francesco Papadia, Maria Francesca Catalano, Flavia Carlini & Nicola Scopinaro

Authors
  1. Gian Franco Adami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Camerini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco Papadia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Francesca Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Flavia Carlini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Renzo Cordera
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nicola Scopinaro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gian Franco Adami.

Ethics declarations

The studies were approved by the local ethical committee, and all patients gave their informed consent.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adami, G.F., Camerini, G., Papadia, F. et al. Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion. OBES SURG 29, 239–245 (2019). https://doi.org/10.1007/s11695-018-3511-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-018-3511-6

Keywords

Search

Navigation